Chlorpromazine PRN Dosing for Agitation and Acute Psychosis
For acute agitation and psychosis in adults, chlorpromazine IM should be initiated at 25 mg, with repeat doses of 25-50 mg every 1 hour as needed until control is achieved, though haloperidol or newer agents are preferred based on superior evidence. 1
Why Chlorpromazine Is Not First-Line
The 2006 emergency medicine guidelines explicitly state that haloperidol has by far the best evidence base among conventional antipsychotics for treating agitation 2. The evidence for chlorpromazine is extremely limited—a 2010 Cochrane review found only one small study (n=30) meeting inclusion criteria, concluding the quality of evidence is "limited, poor and dated" and recommending that "where drugs that have been better evaluated are available, it may be best to avoid use of chlorpromazine" 3.
Most concerning, the 2025 geriatric guidelines found that benzodiazepines (particularly midazolam) pose excessive risk to older adults, with adverse events occurring in 16.8% of patients receiving antipsychotics or anxiolytics for severe agitation 4. While this study didn't specifically evaluate chlorpromazine, it underscores the importance of medication selection in vulnerable populations.
FDA-Approved PRN Dosing Protocol
When chlorpromazine is used, follow this specific algorithm from the FDA label 1:
For Hospitalized Patients with Acute Psychosis/Mania:
Initial dose: 25 mg IM (1 mL)
- If inadequate response after 1 hour: Give additional 25-50 mg IM
- Subsequent doses: Increase gradually over several days, up to 400 mg every 4-6 hours in exceptionally severe cases
- Goal: Patient becomes quiet and cooperative within 24-48 hours, then switch to oral dosing
For Prompt Control of Severe Symptoms:
Initial dose: 25 mg IM (1 mL)
- If needed: Repeat in 1 hour
- Then switch to oral: 25-50 mg three times daily
Critical Safety Requirements:
- Keep patient lying down for at least 30 minutes post-injection to prevent hypotension 1
- Inject slowly, deep into upper outer quadrant of buttock
- Only increase dosage if hypotension has NOT occurred 1
- Monitor blood pressure closely—sudden serious hypotension is a documented risk 3
Special Population Adjustments
Elderly Patients:
Use lower range dosages—elderly patients are more susceptible to hypotension and neuromuscular reactions. Increase dosage more gradually and monitor closely 1. The FDA label explicitly warns about this vulnerability.
Debilitated/Emaciated Patients:
Increase dosage more gradually than in robust patients 1
Major Safety Concerns
Hypotension is the primary acute risk. In the single comparative trial, 2 patients on chlorpromazine developed sudden, serious hypotension versus none on haloperidol 3. One patient developed status epilepticus 3.
Additional risks include:
- QTc prolongation (though less than thioridazine) 2
- Extrapyramidal symptoms (though the single trial found none) 3
- Anticholinergic effects that can worsen agitation from anticholinergic or sympathomimetic toxicity 2
- Leukopenia/agranulocytosis with chronic use 1
Why Other Agents Are Preferred
The evidence hierarchy for acute agitation strongly favors:
- Haloperidol 5 mg IM (with or without lorazepam 2-4 mg)—best evidence base among conventional antipsychotics 2
- Ziprasidone 20 mg IM—Class II evidence showing rapid efficacy with notably fewer movement disorders 2
- Lorazepam 2-4 mg—Class II studies showing equal efficacy to haloperidol 2
Recent meta-analyses (2022-2025) consistently recommend haloperidol with promethazine, olanzapine, or lorazepam as first-tier options, with no mention of chlorpromazine as a preferred agent 5, 6.
When Chlorpromazine Might Be Considered
Historical literature suggests chlorpromazine may be useful when:
- Sedation is specifically desired (unlike haloperidol's more selective calming) 7, 8
- Other agents are unavailable 3
- Patient has responded well to it previously
However, a 1986 paper noted that psychiatric residents "consistently avoid chlorpromazine in favor of haloperidol," suggesting this preference has existed for decades 7.
Critical Pitfall to Avoid
Do not use IV route except for severe hiccups, surgery, or tetanus 1. The FDA label explicitly warns: "AVOID INJECTING UNDILUTED CHLORPROMAZINE HYDROCHLORIDE INJECTION INTO VEIN."